Table 2.

Phenotype analysis of CHS patients’ lymphocytes: Further analysis of CD3⁺, CD4⁺, and CD8⁺ cells

Antigen	Patient 1			Patient 2	Patient 3	Control
	CD3	CD4	CD8	CD3*	CD3*	CD3*
HLA-DR, %	75	66	80	7	14	<15
CD25, %	2	4	0	2	5	<10
CD69, %	0	0	0	1	0	<5
CD28, %	84	99	80	80	92	>80
CD95,† %	70‡	61‡	73‡	59	68	30–60
CD45RO, %	65	54	66	44	59	40–60
CD45RA, %	30	38	25	56	34	40–60
CD40L, %	0	0	0	1	0	<5

Patients were studied at the times described for Table 1. 

^*The results were similar for CD4 and CD8 cells. 

^†Low expression. 

^‡Age-matched control: <30%.